Use our trusted data sets and consultancy to identify, substantiate and communicate the value of your therapeutics, and demonstrate your product’s safety and efficacy in real world settings. Backed by a range of proprietary databases, we can support your evidence strategy to help you achieve and maintain optimal market access.
Our clinical experts conduct observational studies to demonstrate treatment value throughout the product lifecycle, including late-phase and post-marketing non-interventional studies.
Our experienced team helps identify and generate relevant evidence to demonstrate what patients and physicians value, including the benefit/risk trade-offs they’re willing to make when deciding on a treatment.
With real-world qualitative (RWQ) research, we offer rich layers of understanding to strengthen your real-world evidence and fuel your strategic decision-making.
Our market access consultants provide the real-world insights and evidence you need to support your market access and reimbursement strategy.
We leverage decades of experience to design and validate your instruments for evaluating patient-reported outcomes (PRO) and observer-reported outcomes.
We can help build a patient or product registry to support many aspects of your evidence strategy, from clinical trial planning to fulfilling post-authorization requirements.
With electronic health records (EHR) from more than 100 million patients, the size and scope of Oracle EHR Real-World Data is vast and continues to expand thanks to our diverse network of healthcare professionals, researchers, and institutions.
With access to data in more than 10 countries, we can support you in conducting multinational studies in some of the most important regions.
Combining a unique, expansive data set containing more than 100 million patient EHRs with an extensive closed claims database, Oracle can provide you with key insights into the nuances of healthcare costs and treatment patterns.
With more than 2.5 million total respondents since its inception, the Oracle Life Sciences National Health and Wellness Survey provides rigorous patient-reported data, including national projections for more than 200 conditions in 12 countries.
Explore technical support contacts and resources.
Hear from scientists, clinicians, and industry leaders from pharma, biotech and CROs, who are driving innovation in life sciences and health.
Talk to a team member about Oracle solutions for life sciences.